AU6165899A - Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor - Google Patents
Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptorInfo
- Publication number
- AU6165899A AU6165899A AU61658/99A AU6165899A AU6165899A AU 6165899 A AU6165899 A AU 6165899A AU 61658/99 A AU61658/99 A AU 61658/99A AU 6165899 A AU6165899 A AU 6165899A AU 6165899 A AU6165899 A AU 6165899A
- Authority
- AU
- Australia
- Prior art keywords
- zrnp1
- homology
- gnrh receptor
- ribonucleoprotein
- homolog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10351398P | 1998-10-08 | 1998-10-08 | |
US60103513 | 1998-10-08 | ||
US10438198P | 1998-10-15 | 1998-10-15 | |
US60104381 | 1998-10-15 | ||
PCT/US1999/022464 WO2000020583A1 (en) | 1998-10-08 | 1999-09-28 | Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6165899A true AU6165899A (en) | 2000-04-26 |
Family
ID=26800552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU61658/99A Abandoned AU6165899A (en) | 1998-10-08 | 1999-09-28 | Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6165899A (en) |
WO (1) | WO2000020583A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030186849A1 (en) * | 2001-09-06 | 2003-10-02 | Zimmer Robert H. | Modified peptides and their use for the treatment of autoimmune diseases |
US10213482B2 (en) | 2014-12-12 | 2019-02-26 | Immupharma France Sa | Methods of treating chronic inflammatory diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003599A1 (en) * | 1992-08-04 | 1994-02-17 | Sagami Chemical Research Center | HUMAN cDNA AND PROTEIN WHICH SAID cDNA CODES FOR |
AU8116494A (en) * | 1993-11-12 | 1995-06-13 | Kenichi Matsubara | Gene signature |
AU3388597A (en) * | 1996-06-13 | 1998-01-07 | University Of Cape Town | Human type ii gonadotropin-releasing hormone receptor |
-
1999
- 1999-09-28 AU AU61658/99A patent/AU6165899A/en not_active Abandoned
- 1999-09-28 WO PCT/US1999/022464 patent/WO2000020583A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000020583A1 (en) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL353969A1 (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands | |
MXPA02003195A (en) | Safety razors. | |
HK1017264A1 (en) | Use of substituted imidazolidin-2,4-diones as analgesics. | |
HUP9903445A3 (en) | 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists | |
EP1041888A4 (en) | Anti-retroviral immunogens, preparation and use | |
ZA200205333B (en) | Skin moisturizing composition. | |
ZA200110536B (en) | 1,2,3,4,5,6-hexahydroazepino [4,5-b]indoles containing arylsulfones at the 9-position. | |
EG23909A (en) | Vatamin d, analogs | |
MXPA02001686A (en) | Hydrocyclone. | |
HK1045684A1 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor. | |
HK1027606A1 (en) | Shower combination. | |
MXPA02005104A (en) | Novel bicyclic cannabinoid agonists for the cannabinoid receptor. | |
ZA200109206B (en) | Preparation of substituted piperidin-4-ones. | |
AU6165899A (en) | Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor | |
GB0029720D0 (en) | I.S machine7544232001 | |
GB0126074D0 (en) | Tomographic system | |
ZA200107738B (en) | Optically pure camptothecin analogues. | |
GB9907861D0 (en) | The tracker | |
AU2284401A (en) | Galactosyltransferase homolog, znssp8 | |
AU6142900A (en) | Avalanche safety vest | |
ZA200204455B (en) | Use of dopamine-D3 receptor agonists for the therapy of salt-dependent hypertension. | |
AU2503800A (en) | Beta-1,3-galactosyltransferase homolog, znssp6 | |
GB2353006B (en) | Sheathed Safety buoy | |
PL343639A1 (en) | Anchoring means, especially for balcony attachments | |
ZA200001571B (en) | Switch point. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |